Skip to main content

Table 2 Comparison of background parenchymal uptake, assessed quantitatively, on pre-tamoxifen and post-tamoxifen MBI

From: Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study

 

Quantitative BPU on pre-tamoxifen MBI, mean (sd, range)

Quantitative BPU on post-tamoxifen MBI, mean (sd, range)

% change, mean (sd, range)

p

Overall (n = 21)

1.43 (0.32, 0.81–2.17)

1.34 (0.38, 0.74–2.10)

− 6.1% (17%, − 31 to + 45%)

0.11

Women taking 5 mg tamoxifen (n = 10)

1.53 (0.30, 1.12–2.17)

1.51 (0.34, 1.13–2.10)

0.0% (21%, − 24.0 to + 45%)

0.99

Women taking 10 mg tamoxifen (n = 11)

1.34 (0.32, 0.81–2.13)

1.19 (0.35, 0.74–1.75)

− 12% (11%, − 31 to + 7%)

0.005

  1. BPU background parenchymal uptake, MBI molecular breast imaging